Illumina Inc (ILMN) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $239.62 (-2.27%), Market cap $21.57B, P/E ratio 25.92, 52-week low–high $79.37 ~ $153.95.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic inst
Financial statements, price targets, institutional (13F) holdings and related news for Illumina Inc are updated in real time on BlackAll Trade.
Illumina Inc trades at $239.62 (-2.27%). Real-time quotes and charts are available on BlackAll Trade.
Illumina Inc has a market cap of about $21.57B. Its P/E ratio is 25.92.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers